Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Metronidazole and Propranolol Methimazole and Propranolol Metronidazole and Propylthiouracil Methimazole and Propylthiouracil None 2. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Radiation pneumonitis Gastritis Myelosuppression Leukemia None 3. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Blocking thyroid uptake of free radioiodine Reviewing potential interfering medications Performing pulmonary function tests None 4. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Performing pulmonary function tests Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine None 5. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 6 months. With the birth of another child. After 3 months. Never. None 6. Which of the following property of radiation is principally used in the treatment of tumors? Photographic effect Chemical effect Biologic effect Fluorescent effect None 7. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Arrhythmia Bruising Anemia Fever None 8. Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called: Super scan. Super phenomenon. Flare scan. Flare phenomenon. None 9. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Antibody therapy. Radiation therapy. Radiochemotherapy. Radioimmunotherapy. None 10. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient should use antiperspirant medications Patient should be well hydrated Patient laxatives Patient should urinate frequently None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-03-30T09:35:30+03:00March 30th, 2021| شارك هذه الصفحة FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave A Comment Cancel replyComment Δ
Leave A Comment